Results 171 to 180 of about 26,501 (228)

Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinoma. [PDF]

Theranostics
Yilmaz EY, Schmidt R, Heidemann L, He Y, Liu Y, Sulejmani O, Müller DN, Wilhelm A, Auer TA, Hamm CA, Abosabie SAS, Abosabie SA, Gebauer B, Savic LJ.   +13 more
europepmc   +1 more source

Transarterial Chemoembolization Versus Transarterial Radioembolization in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trial Evidence. [PDF]

Cancers (Basel)
Gogna P, Wang C, Underwood D, Farid-Kapadia M, Dasari M, Pyne T, Sinha N, Stirnadel-Farrant HA, Valerio SJ.   +8 more
europepmc   +1 more source

Development and validation of a clinical-adipometric nomogram for predicting tumor response to transarterial chemoembolization in hepatocellular carcinoma. [PDF]

Sci Rep
Zhao J, Fu G, Wang Y, Yang H.
europepmc   +1 more source

Efficacy and safety of transarterial chemoembolization (TACE) with tislelizumab and tyrosine kinase inhibitors versus TACE for intermediate and advanced HCC. [PDF]

J Cancer Res Clin Oncol
Tang S, Yan X, Gong T, Zhi W, Gao Y, Han Y.   +5 more
europepmc   +1 more source

Right or Left: Which Is the Right Radial Access for Liver Transarterial Chemoembolization? [PDF]

Diagnostics (Basel)
Giurazza F, Corvino F, D'Antuono F, Carrubba C, Roccatagliata P, De Martino F, Pirozzi Palmese V, Capussela T, Niola R.   +8 more
europepmc   +1 more source

Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma. [PDF]

Cancer Manag Res
Wang D, Zhang W, Gao X, Kong H, Zhang H, Huang J, Zhang M, Chang X, Zeng Z.   +8 more
europepmc   +1 more source

Refining prognostication in intermediate-stage hepatocellular carcinoma after transarterial chemoembolization: promise and limitations of the proposed NTAA model. [PDF]

Hepatobiliary Surg Nutr
Schindler P, Masthoff M.
europepmc   +1 more source

Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in Japan. [PDF]

Liver Cancer
Tanaka T, Anai H, Masada T, Sueyoshi S, Sato T, Toyoda S, Matsumoto T, Chanoki Y, Oshima K, Shimizu S, Irizato M, Taiji R, Minamiguchi K, Kunichika H, Kurakami H, Ichihashi S, Nishiofuku H.   +16 more
europepmc   +1 more source

Artificial intelligence in transarterial chemoembolization for hepatocellular carcinoma: from treatment response prediction to refractoriness assessment. [PDF]

Front Oncol
Ma X, Wang J, Li H.
europepmc   +1 more source

Comparison of the efficacy of transarterial chemoembolization combined with radiofrequency ablation or sintilimab and bevacizumab for unresectable hepatocellular carcinoma. [PDF]

BMC Gastroenterol
Li T, Zhao H, Dong C, Song Y, Li M.
europepmc   +1 more source